BioSpace News Archive

HansBiomed USA makers of MINT PDO Wins “Top Medical Thread Device”, “Top Aesthetic Company” and “Top Professional Team” in the Aesthetic Everything® 2020 Aesthetic and Cosmetic Medicine Awards . Voting was held online between January 13th and February 7th, 2020 , with winners being announced on February 8th, 2020

Micro-Tech Endoscopy USA continues a streak of new product launches in their hemostasis portfolio with the In-Sight™ Multi-Band Ligator.

OpSens Inc. today announced it will be presenting at the LD 500 investor conference on Tuesday, September 1st at 10:20 AM Eastern Time (7:20 AM Pacific Time).

On July 20th of 2020, healthcare executive Wendy Edwards was promoted to CEO for the Oregon-based Medical Advantage health plan provider, ATRIO Health Plans.

PT CE and NCODA to Partner in Bringing Oncology-Focused Continuing Education to the NCODA Membership The industry-leading continuing pharmacy education provider becomes sole provider for association’s three major meetings through 2021 CRANBURY, N.J.--( BUSINESS WIRE )-- PT CE proudly announces it is now the exclusive continuing education (CE) provider for the National Community Oncology Dispensing Association, Inc. (NCODA) 2020-2021 meetings. N

Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will open a free 24-hour crisis line for all individuals impacted by the wildfires in California.

- In lieu of an in-person update to the media, Dr. Theresa Tam , Canada’s Chief Public Health Officer, issued the following statement today: “There have been 125,969 cases of COVID-19 in Canada , including 9,090 deaths. 89% of people have now recovered. Labs across Canada tested an average of almost 48,000 people daily over the past

Chef Jonah Nissenbaum, most recently the executive sous chef at Ralph Brennan’s Red Fish Grill in New Orleans, has started in the newly created position as Executive Chef for Sterling Surgical Hospital in Slidell, Louisiana, the hospital announced today.

It’s time to end the stigma of mental health in the black communities and start addressing our traumas so we can work collectively, productively and fruitfully, to contribute to wealth building in our communities. Abu Simbel, LLC event company

Stoke Therapeutics Announces Publication of Preclinical Data on STK-001 in the Journal Science Translational Medicine that Demonstrate Significant Improvements in Survival and Reductions in Seizure Frequency in a Dravet Syndrome Mouse Model STK-001 has the potential to be the first disease-modifying therapy to address the genetic cause of Dravet syndrome A Phase 1/2a study of STK-001 in children and adolescents ages 2 to 18 years old is now underway